Discover
TELA
TELA Bio, Inc.
1.07
2 x 0.66
2 x 1.18
bid
ask
-
0.02
1.83%
2 @ 04:00 PM
1.07 +0.00 (0.00%)
| Ytd | -9.32% | |
| 1y | -31.85% |
1.03
day range
1.11
0.50
52 week range
1.56
| Open | 1.07 | Prev Close | 1.09 | Low | 1.03 | High | 1.11 | Mkt Cap | 48.30M |
| Vol | 168.06K | Avg Vol | 213.37K | EPS | -0.76 | P/E | N/A | Forward P/E | -4.31 |
| Beta | 1.36 | Short Ratio | 1.28 | Inst. Own | 51.68% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 0.92 | 200-d Avg | 0.87 | 1yr Est | 9.20 |
| Income Statement | |||
| Total Revenue | 19.29M | ||
| Revenues (USD) | 19.29M | ||
| Cost of Revenue | 5.35M | ||
| Gross Profit | 13.94M | ||
| Operating Expenses | 23.23M | ||
| Research and Development Expense | 2.72M | ||
| Selling, General and Administrative Expense | 20.50M | ||
| Operating Income | -9.28M | ||
| Interest Expense | 2.08M | ||
| Income Tax Expense | 60.00K | ||
| Net Income | -11.26M | ||
| Net Income Common Stock | -11.26M | ||
| Net Income Common Stock (USD) | -11.26M | ||
| Consolidated Income | -11.26M | ||
| Earnings per Basic Share | -0.20 | ||
| Earnings per Basic Share (USD) | -0.20 | ||
| Earnings per Diluted Share | -0.20 | ||
| Earning Before Interest & Taxes (EBIT) | -9.13M | ||
| Earning Before Interest & Taxes (USD) | -9.13M | ||
| Weighted Average Shares | 57.41M | ||
| Weighted Average Shares Diluted | 57.41M | ||
| Balance Sheet | |||
| Cash and Equivalents | 30.62M | ||
| Cash and Equivalents (USD) | 30.62M | ||
| Trade and Non-Trade Receivables | 9.64M | ||
| Current Assets | 54.49M | ||
| Property, Plant & Equipment Net | 3.43M | ||
| Total Assets | 59.74M | ||
| Total Debt | 56.08M | ||
| Current Liabilities | 18.22M | ||
| Debt Non-Current | 56.08M | ||
| Total Liabilities | 75.60M | ||
| Accumulated Retained Earnings (Deficit) | -421.10M | ||
| Accumulated Other Comprehensive Income | 84.00K | ||
| Shareholders Equity | -15.87M | ||
| Shareholders Equity (USD) | -15.87M | ||
| Assets Non-Current | 5.25M | ||
| Total Debt (USD) | 56.08M | ||
| Goodwill and Intangible Assets | 1.17M | ||
| Inventory | 11.06M | ||
| Liabilities Non-Current | 57.39M | ||
| Trade and Non-Trade Payables | 2.88M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 266.00K | ||
| Net Cash Flow from Financing | -15.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -9.17M | ||
| Capital Expenditure | -59.00K | ||
| Net Cash Flow - Business Acquisitions and Disposals | 298.00K | ||
| Net Cash Flow from Investing | 239.00K | ||
| Net Cash Flow from Operations | -9.38M | ||
| Effect of Exchange Rate Changes on Cash | -10.00K | ||
| Share Based Compensation | 613.00K | ||